- EpiPen Price Hike Has Parents of Kids With Allergies Scrambling Ahead of School Year
- Following a recall by Mylan’s chief competitor last year, the company now enjoys a near monopoly.
- Doctors and patients say the Mylan pharmaceutical company has jacked up the prices for an EpiPen – the portable device that can stop a potentially life-threatening allergic reaction – from around $100 in 2008 to $500 and up today.
- Connecticut Senator Richard Bluemnthal, who pushed for emergency epinephrine to be stocked in public schools, pledged Friday to investigate the “shocking increase.”
Read the full article, click here.
@SteveSaleeba: “Prob safe to assume #PriceGouging @MylanNews CEO Heather Bresch’s kids don’t suffer any life-threatening allergies:”
The cost of saving your child’s life has gotten a lot more expensive.
EpiPen Price Hike Has Parents of Kids With Allergies Scrambling Ahead of School Year